This resource was selected by SMI Adviser content partners and approved by the SMI Adviser clinical expert team for inclusion in the knowledge base.
This article examines diabetes screening among publicly insured adults with SMI taking antipsychotic medications using matched administrative data for physical and mental health care services in a large health care system. The article also discusses diabetes screening prevalence among patients with SMI treated with antipsychotic medications and assessed characteristics predictive of screening.